US 7,888,472 B2Granted

Optimized multi-epitope constructs and uses thereof

AssigneesEpimmune Inc., Genimmune N.V.

InventorsAlessandro Sette, Robert Chesnut, Mark J. Newman, Brian D. Livingston, Lilia Maria Babe, Yiyou Chen, Lawrence M. Deyoung, Manley T. F. Huang, Scott D. Power

Life of this patent

Estimating the term…

Abstract

The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.

Claims6

Dependent claims

An isolated polypeptide encoded by a polynucleotide selected from the group consisting of:

SEQ ID NO:205 and SEQ ID NO:207.

Dependencies are inferred from the claim text.

Facts

Application: 12/408,472Filed 20 Mar 2009 · division
Priority: 3 Oct 2002
Published: US 2010/0068218 A118 Mar 2010
Granted: 15 Feb 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 39/292
Hepatitis virus: serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
A61P 31/20
Antivirals: for DNA viruses
C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses

Family

Application60/415,463Us provisional application · filed 3 Oct 2002
Application60/419,973Us provisional application · filed 22 Oct 2002
Application10/677,754Parent of this division · filed 3 Oct 2003
US 2010/0068218 A1Pre-grant publication · published 18 Mar 2010
US 7,507,803 B2Parent of this division
US 2007/0048330 A1Published application
US 7,888,472 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results